Fulgent Genetics (NASDAQ: FLGT)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 3.860 | 5.080 | 1.2200 | ||||
REV | 270.850M | 320.268M | 49.418M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Fulgent Genetics (NASDAQ: FLGT) through any online brokerage.
Other companies in Fulgent Genetics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Signify Health (NYSE:SGFY), LHC Gr (NASDAQ:LHCG) and Agiliti (NYSE:AGTI).
The latest price target for Fulgent Genetics (NASDAQ: FLGT) was reported by Piper Sandler on Monday, May 16, 2022. The analyst firm set a price target for 70.00 expecting FLGT to rise to within 12 months (a possible 26.08% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Fulgent Genetics (NASDAQ: FLGT) is $55.52 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Fulgent Genetics.
Fulgent Genetics’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Fulgent Genetics.
Fulgent Genetics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.